Community and Patient Preference Research (CAPPRE), on behalf of a pharmaceutical company, is conducting research with people living with CLL in Australia and New Zealand to explore their experiences with the healthcare system. CaPPRe is an independent research company based in Sydney which works closely with industry, academia, and government to encourage patient involvement and choice in healthcare decision making.
Your participation is valuable in understanding the impact of CLL on people’s lives. This information helps improve the understanding of what your treatment goals are and what is important to you with treatment for this condition.
Visit survey.confirmit.com.au/wix... to check if you are eligible to participate in the 30-40 minute on-line survey. Please use a laptop, desktop computer, or large tablet (>10"/250mm) to complete the survey. Mobile phones and mini tablets will not be suitable.
In appreciation for your time and contribution to the research, you will receive a payment of A$75 or NZ$75 respectively for completion of the full survey. You will have the option of receiving a report of the findings. Participation is voluntary and you are free to withdraw at any time.
Need more information? Contact Rose Wilson at rose.wilson@cappre.com.au or call +61 468 435 926. A reminder, this survey is open to those with a CLL diagnosis living in New Zealand and Australia only. Carers can assist you with the survey response. You might be surprised how much your carer is aware of ways that you minimise the impact of CLL on your life, so I'd recommend welcoming their assistance.
Note that CLL Support UK will receive referral fees for completed surveys. Any fees received will go towards the charity's project to help people with CLL/SLL in their emotional/mental problems - particularly at diagnosis and Watch and Wait. I've seen how learning that we have CLL and that nothing will be done (watch and worry ) can sometimes have a greater impact on our mental and physical health than the actual CLL does, so it's a great initiative.
This is an open, unlocked post, so that it will reach more Australians and New Zealanders.
Neil
19 September 2022 Updated to include New Zealand residents
21 September 2022 Updated to note survey device requirements